Organon (OGN) Receivables (2020 - 2026)
Organon (OGN) posted quarterly Receivables of $1.5 billion for Q2 2026, up 0.54% year-over-year from $1.5 billion in Q2 2025, and up 7.8% on a QoQ basis from $1.4 billion in Q1 2026.
Organon (OGN) Receivables (2020 - 2026) Analysis & Trends
Organon has reported Receivables for 7 years, with the latest figure at $1.5 billion in Q2 2026.
- Receivables for Q2 2026 came in at $1.5 billion, up 0.54% year-over-year; the trailing twelve-month figure through Jun 2026 was $1.5 billion (up 0.54% YoY), and the FY2025 annual result was $1.3 billion, down 1.99% from the prior year.
- Receivables climbed to $1.5 billion in Q2 2026, from $1.4 billion in the prior quarter.
- Over five years, Receivables peaked at $1.9 billion in Q2 2022 and troughed at $1.3 billion in Q4 2025.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2023 frame the typical range for Receivables.
- The largest YoY upside for Receivables was 66.34% in 2022 against a maximum downside of 23.22% in 2022.
- A 5-year view of Receivables shows it stood at $1.8 billion in 2022, then dropped by 5.68% to $1.7 billion in 2023, then fell by 22.13% to $1.4 billion in 2024, then fell by 1.99% to $1.3 billion in 2025, then rose by 12.1% to $1.5 billion in 2026.
- Per Business Quant data, the three most recent Receivables figures were $1.5 billion in Q2 2026, $1.4 billion in Q1 2026, and $1.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.86 Bn | 633.10 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.11 Bn | 463.54 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 375.28 Bn | 368.14 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 302.83 Bn | 295.14 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.33 Bn | 252.43 Bn | 12.86 Bn | 14.33 Bn |
| 6 | Amgen | 237.21 Bn | 223.22 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 183.09 Bn | 179.91 Bn | 6.22 Bn | 5.90 Bn |
| 8 | Pfizer | 160.08 Bn | 148.39 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn | 10.34 Bn |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 1.49 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | 1.38 Bn |
| Dec 31, 2025 | 1.33 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 1.46 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.69 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.55 Bn |
| Dec 31, 2023 | 1.74 Bn |
| Sep 30, 2023 | 1.65 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.79 Bn |
| Dec 31, 2022 | 1.85 Bn |
| Sep 30, 2022 | 1.85 Bn |
| Jun 30, 2022 | 1.92 Bn |
| Mar 31, 2022 | 1.68 Bn |
| Dec 31, 2021 | 1.79 Bn |
| Sep 30, 2021 | 2.41 Bn |